Abstract

In recent years, there has been a major advance in the treatment of pulmonary hypertension. New medications are continually added to the therapeutic arsenal. The prostanoids are among the first agents used to treat pulmonary hypertension and are currently considered the most effective. This case study describes a 63-year-old man who was diagnosed with chronic thromboembolic pulmonary hypertension and successfully treated with subcutaneously administered treprostenil for 6 months before a successful pulmonary thromboendarterectomy. Treatment of chronic thromboembolic pulmonary hypertension often requires a multidisciplinary approach before surgery. Further evaluation of prostanoids is needed to define their role and time of initiation of medical therapy in these patients.

Details

Title
Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report
Author
Porpodis, Konstantinos; Konoglou, Maria; Zarogoulidis, Paul; Kaimakamis, Evangelos; Kontakiotis, Theodoros; Papakosta, Despoina; Zervas, Vasilis; Katsikogiannis, Nikolaos; Courcoutsakis, Nikolaos; Mitrakas, Alexandros; Touzopoulos, Panagiotis; Karanikas, Michael; Zarogoulidis, Konstantinos; Markopoulou, Aikaterini
Pages
767-772
Section
Case report
Publication year
2011
Publication date
2011
Publisher
Taylor & Francis Ltd.
e-ISSN
1178-7074
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2222440447
Copyright
© 2011. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.